LEIPZIG, Germany: The fourth quarter of 2025 yielded indicators of growth within the North American dental marketplace, together with US distributor massive Henry Schein posting its very best enlargement in just about 4 years, and affirmation of an uptick in diagnostics gross sales after 3 years of contraction. Regardless of a slowdown in implant remedies in China, the quarter used to be in large part certain. Then again, because the effects had been delivered previous to the battle within the Heart East, which has disrupted international power networks and affected dental affected person site visitors around the area, they would possibly not point out a robust begin to 2026. This newsletter takes a better take a look at how the 4 biggest dental producers carried out all through the duration.
Align Era celebrates 22 million aligners
At Align Era, earnings for the fourth quarter reached US$1.05 billion (€892.50 million*), up through 5.3% yr on yr. The corporate shipped 676,885 aligners all through the duration, a fourth-quarter report representing a 7.7% year-on-year achieve.
In line with the corporate’s income commentary, gross sales of orthodontic home equipment and units had been strong in North The us and powerful within the Europe, Heart East and Africa (EMEA), Latin The us and Asia-Pacific areas. Align earned US$838.15 million from aligner gross sales, a 5.5% year-on-year building up. Revenues from imaging techniques and CAD/CAM services and products reached US$209.42 million, a 4.2% year-on-year achieve that mirrored iTero Lumina intra-oral scanner quantity positive factors and upgrades.
Source of revenue for the total yr totalled US$4.03 billion, which represented a flat year-on-year comparability. This incorporated US$3.25 billion earned from Invisalign, and US$789.56 million earned from imaging techniques and CAD/CAM services and products.
John F. Morici, leader monetary officer and government vice-president of worldwide finance at Align, stated within the income commentary that the fourth quarter “used to be a excellent end to the yr, with effects that got here in higher than anticipated and mirror the ongoing power of our industry basics”. Morici added that the corporate used to be inspired through dental marketplace stipulations, being cautiously constructive regardless of a difficult macroeconomic atmosphere.
Within the fourth quarter, Align shipped aligners to its 22 millionth affected person. Teenagers and youngsters have accounted for six.5 million of the full aligner remedies delivered through the corporate. The profitable marketplace for treating more youthful orthodontic sufferers helped to stabilise Align all through turbulent dental marketplace stipulations that started with the SARS‑CoV‑2 pandemic, and the corporate has controlled to maintain enlargement on this house. CEO Joseph M. Hogan stated that 935,800 teenagers and youngsters underwent Invisalign remedy in 2025—7.8% greater than the former yr.
Envista Holdings notes diagnostics uptick
Envista Holdings Corp. reported US$750.6 million in gross sales for the fourth quarter, indicating a core gross sales enlargement of 10.8% yr on yr.** Eric Hammes, Envista’s leader monetary officer, informed analysts in an income name that year-on-year gross sales enlargement used to be recorded around the corporate’s industry devices, albeit in opposition to a vulnerable similar quarter final yr in its China and international diagnostics companies. Hammes cited above-average efficiency in North The us implant gross sales all through the duration, specifically within the classes of virtual and regenerative implant answers. Additional enhancements within the corporate’s North American industry had been noticed within the house of diagnostics, which recorded a 3rd consecutive quarter of gross sales enlargement.
“Remaining yr, we described the dental marketplace as sluggish however strong. On steadiness, that’s nonetheless the most efficient descriptor.”—Paul Keel, CEO, Envista
Envista posted gross sales of US$2.7 billion for the total yr, representing 6.5% core gross sales enlargement. CEO Paul Keel stated that the expansion used to be broad-based and unfold around the portfolio.
Talking in regards to the world dental marketplace in the similar income name, Keel commented: “Throughout maximum of final yr, we described the dental marketplace as sluggish however strong. On steadiness, that’s nonetheless the most efficient descriptor, even though we’re starting to see some indicators of marketplace growth.”
He added: “As an example, the North American diagnostic marketplace returned to enlargement in [the second half of the year], and [the fourth quarter] used to be the 3rd directly quarter the place all of our companies posted certain enlargement. As we’re a most sensible 3 participant in all of our classes, the breadth and consistency of our efficiency must be a favorable sign for the wider marketplace as smartly.”
Straumann weathers second-half slowdown in China
Fourth-quarter gross sales at Straumann Crew totalled CHF 655.0 million (€704.7 million*), up through 1.5% yr on yr—7.0% on an natural foundation.** All through the duration, the corporate’s industry expanded within the EMEA area, which accounted for just about 1/2 of all Straumann’s fourth-quarter earnings, and declined in Asia-Pacific. For the total yr, Straumann reported CHF 2.6 billion in earnings, up through 4.1%.
Fourth-quarter EMEA gross sales of CHF 299.9 million had been up through 13.2%, pushed through sturdy momentum in Germany and Austria and the Benelux and Iberian dental markets. In Latin The us, gross sales of CHF 60.8 million represented a 17.9% achieve, boosted through implant gross sales in Brazil, the area’s most sensible performer.
The CHF 170.3 million banked from gross sales in North The us represented natural gross sales enlargement of 6.8% and a decline of two.7% in Swiss francs. All through the duration, macroeconomic stipulations available in the market remained unsure, Straumann stated; alternatively, resilient call for for implant answers and returns from the corporate’s funding in its dental make stronger organisation industry introduced sequential growth.
In Asia-Pacific—an an increasing number of decisive marketplace for main dental producers—Straumann’s gross sales of CHF 123.9 million represented a drop of nineteen.3%. Straumann’s gross sales within the area had skilled an extraordinary dip within the prior quarter, and the most recent income consequence showed a protracted slowdown in implant gross sales in China. The rustic’s volume-based procurement has helped implant producers to transport huge volumes of product; alternatively, delays within the procurement procedure have limited affected person glide and resulted in destocking.
Talking with analysts in an income name, Straumann CEO Guillaume Daniellot stated that the corporate used to be not off course with its industry in China, the place 7% enlargement used to be recorded over the total yr. He stated that the corporate used to be taken with its core and enlargement marketplace segments. Of the estimated CHF 6.1 billion annual international implant marketplace, Straumann holds a proportion of 35%, Daniellot stated. He added that the corporate used to be increasing its proportion of the CHF 1.3 billion regenerative answers marketplace—it lately holds 13%—and aiming to develop its orthodontics gross sales to seize a better portion of the worldwide orthodontics marketplace. Straumann holds lower than 5% of the marketplace’s estimated price of CHF 4.9 billion.
Information experiences in March indicated that the continuing battle within the Heart East might extensively have an effect on the efficiency of worldwide dental markets within the first quarter. (Symbol: Dragana Gordic/Adobe Inventory)
Dentsply Sirona slashes internet loss
Internet gross sales at Dentsply Sirona within the fourth quarter reached US$961 million, up through 6.2% yr on yr. America dental massive made growth in its purpose of returning to profitability, regardless of bearing a US$153 million fee for goodwill and intangible asset impairment. It posted a internet lack of US$145 million—considerably less than its US$428 million loss a yr previous. Mike Pomeroy, meantime leader monetary officer, informed analysts in an income name that the fee used to be associated with quantity declines and the have an effect on of price lists throughout the corporate’s hooked up generation answers (CTS) and orthodontic and implant answers (OIS) companies.
CTS gross sales reached US$299 million, a 1.8% building up; gross sales of very important dental answers (EDS) reached US$372 million, up through 7.8%; and the ones of OIS totalled US$202 million, a achieve of 9.8%. Robust effects had been recorded in the USA, the place CTS and EDS gross sales larger through 9.0% and three.7%, respectively, and the place OIS gross sales larger through 52.2%. In Europe, gross sales of CTS had been flat, at 0.9% enlargement, gross sales of EDS recorded an 8.6% building up and OIS gross sales larger through 3.6%. Cumulative gross sales for all different markets had been much less buoyant. EDS gross sales climbed through 12.0%, and gross sales of CTS and OIS declined through 3.2% and 16.8%, respectively.
Dental implants are a key pillar of Dentsply Sirona’s enlargement technique. Pomeroy stated that single-digit enlargement of implant gross sales have been recorded in China within the first 1/2 of the yr, adopted through a double-digit decline caused through the build-up to China’s moment section of volume-based procurement in 2026.
Internet gross sales for 2025 at Dentsply Sirona had been US$3.68 billion, down through 3% in comparison with the former yr. Internet loss for the total yr used to be US$598 million in comparison with a US$910 million internet loss in 2024.
Addressing analysts in a convention name, CEO Daniel Scavilla stated that the effects had been in keeping with the management’s expectancies. Pointing to the paintings forward, he stated that the corporate used to be present process a targeted transformation, “now not a momentary reset”, and that it could “give a boost to execution and ship sustained successful enlargement”.
